Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Susan L. Lindquist

Susan L Lindquist, Anne Jacobson

    Trends in Cell Biology
    |February 23, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer.

    The oncologist·2022
    Same author

    Benefits of Adjuvant Chemotherapy Differ by Menopausal Status in Women with HR+/HER2- Early Breast Cancer, 1-3 Positive Nodes, and a Low Recurrence Score.

    The oncologist·2022
    Same author

    Elacestrant Improves Progression-Free Survival After Endocrine Therapy for Estrogen Receptor-Positive Metastatic Breast Cancer.

    The oncologist·2022
    Same author

    Pyrotinib Improves Survival in Previously Treated HER2-Positive Metastatic Breast Cancer.

    The oncologist·2022
    Same author

    Early Switch to Fulvestrant Plus Palbociclib Improves Outcomes in ESR1-Mutated, Estrogen Receptor-Positive Metastatic Breast Cancer.

    The oncologist·2022
    Same author

    Alpelisib Plus Fulvestrant or Letrozole Demonstrates Sustained Benefits Across Subgroups of Patients with PIK3CA-Mutated HR+/HER2- Advanced Breast Cancer.

    The oncologist·2022
    Same journal

    Horizontal transfer of mitochondria in cancer: The physiology reborn in disease?

    Trends in cell biology·2026
    Same journal

    Spindle errors: A stress test for epithelial robustness.

    Trends in cell biology·2026
    Same journal

    Multicellular ecosystems: Linking cellular diversity to tissue function and disease.

    Trends in cell biology·2026
    Same journal

    Orchestrating the signaling-bias at the protease-activated receptor, PAR1.

    Trends in cell biology·2026
    Same journal

    Crashing by design: Utilizing DNA damage for MCC differentiation.

    Trends in cell biology·2026
    Same journal

    The value of a shared lab: Our insights.

    Trends in cell biology·2026
    See all related articles